期刊文献+

乳腺癌组织中p33^(ING1b)和p^(53)及C-erbB-2表达对预后评估的意义 被引量:2

Expression of p33^(ING1b),p^(53) and C erbB-2 in breast carcinoma tissue in relation to clinical significance of prognosis
下载PDF
导出
摘要 目的:探讨p33ING1b,p53,原癌基因C-erbB-2在乳腺癌的发生发展中的生物学特征及其对预后评估的意义。方法:应用EVISION免疫组化法,检测了80例乳腺癌标本中C-erbB-2,p33ING1b,p53的表达,及13例癌旁正常组织p33ING1b的表达。结果:乳腺癌组及对照组中p33ING1b均阳性表达,乳腺癌组织中表达犤65%(52/80)犦有明显下降,两组之间差异有显著性意义(χ2=25.138,P<0.01),p33ING1b,p53,C-erbB-2在乳腺癌组织中表达阳性率分别为65%,60%,61%。其中p33ING1b的表达与雌激素受体和孕激素受体水平呈正相关(r=0.371,r=0.537,P<0.05)p33ING1b,p53与肿瘤大小、腋窝淋巴结有无转移呈负相关(r=-2.09,r=-0.537,P<0.05)。C-erbB-2与组织学分级,淋巴结有无转移呈正相关(r=0.371,P<0.05),与雌、孕激素受体水平呈负相关(r=-0.387,r=-0.440,P<0.05)。结论:p33ING1b基因的表达可能需要p53基因的协同,两者共同作用于细胞的生长、凋亡和转化,保证机体发挥正常的功能,抑制肿瘤的发生。ING1是抑癌基因,其蛋白p33ING1b在乳腺癌中低表达,对乳腺癌的发生发展可能起重要作用,p33ING1b,p53,C-erbB-2可作为判断乳腺癌恶性程度及预后的重要指标。 AIM:To probe into the biological characters of p33ING1b,p53,C erbB 2 in the happening and development of breast carcinoma and its clinical signification. METHODS:The expression of C erbB 2,p33ING1b,p53 of 80 specimens of breast carcinoma and the expression of p33ING1b of 13 juxtacancerous tissue were detected with EVISION immunohistochemical method. RESULTS:The expressions of p33ING1b in breast carcinoma group and control group were positive,65%(52/80) of the expression of breast carcinoma tissue in breast carcinoma group was extremely decreased,significantly different from the other group(χ2=25.138, P< 0.01). The positive rates of p33ING1b,p53,and C erbB 2 expression were 65%,60%,and 61%respectively.The expression of p33ING1b was positively correlation with the level of estrogen receptor(ER) and progestogen receptor(PR)(r=0.371,r=0.537,P< 0.05),and the expression of p33ING1b,p53 were negatively correlation with tumor size and lymph node metastases(r=-2.09,r=-0.537,P< 0.05). The expression of C erbB 2 were positively correlation with histological grading and lymph node metastases(r=0.371,P< 0.05),and they were negatively correlation with the level of ER and PR(r=-0.378,r=-0.440,P< 0.05) CONCLUSION:The expression of p33ING1b gene may be cooperative with p53,and both of them cooperate on the growth,apoptosis and conversion of cells to ensure the normal function of the organism and inhibit the happening of oncology.ING1 is a tumour suppressor gene, its p33ING1b expression in carcinoma of breast is low,and plays an important role in the breast carcinogenesis and development.The p33ING1b,p53,C erbB 2 expression can be used as an important indicator for differentiating malignancy and prognosis of breast carcinoma.
作者 章烨 王雅杰
出处 《中国临床康复》 CSCD 2004年第32期7212-7214,i006,共4页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献9

  • 1Ambros RA, Vigna PA, Figge J, et al. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on P53. Cancer 1994;74:1686
  • 2Kamb A, Orais NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 4(2): 436 - 8
  • 3Garkavtsev I, Kazarov A, Gudkov K, et al. Suppression of the novel growth inhibitor P33 ING1 promotes neoplastic transformation. Nat Genet 1996; 14(4): 415 -20
  • 4Helbing G, Veillette C, Riabowol K, et al. A novel candidate tumor suppressor, ING1 is involved in the regulation of apoptosis. Cancer Res 1997;57(7): 1255 - 8
  • 5Shinoura N, Muramatsu Y, Nishimura M, et al. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas. Cancer Res 1999;59(21):5521 - 8
  • 6Turovets NA, Agapova LS, Kopnin PB, et al. Effect of inactivating the p33ING1tumor suppressor on the function of cell cycle ''checkpoints'' and genome stability. Genetika 2000;36(3): 385 -92
  • 7Garkavtsev I, Riabowol K. Extension of the replicative life span of human diploid fibroblast by inhibition of the P33 ING1, candidate tumor suppression. Mol Cell Biol 1997; 17(4): 2014 - 9
  • 8Kuzmichev A, Zhang Y, Erdjument Bromage H, et al. Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1). Mol Cell Biol 2002; 22 (3): 835 - 48
  • 9Nouman GS, Anderson JJ, Crosier S, et al. Downregulation of nuclear expression of the p33 (INGIb) inhibitor of growth protein in invasive carcinoma of the breast. J Clin Pathol 2003; 56 (7): 507 - 11

同被引文献11

  • 1许红霞,吴伟平,俞文菊.PTEN和nm23H_1基因表达与上皮性卵巢癌淋巴转移的关系[J].现代实用医学,2005,17(8):499-499. 被引量:2
  • 2Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235(4785): 177 - 82.
  • 3Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto oncogene in human breast and ovarian cancer. Science 1989; 244 (4905): 707 -12.
  • 4Makar AP, Desmedt EJ, De Potter CR, et al. Neu (C-erbB-2) oncogene in breast cancer and its possible association with the risk of distant metastases. A retrospective study and review of literature. Acta Oncol 1990; 29 (7): 931 - 4.
  • 5Corbett IP, Henry JA, Angus B, et al. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. J Pathol 1990; 161 ( 1 ): 15 - 25.
  • 6Soomro S, Shousha S, Taylor P, et al. c-erbB-2 expression in different histological types of invasive breast carcinoma. J Clin Pathol 1991; 44 (3): 211 - 4.
  • 7Tanner M, Jarvinen P, Isola J. Amplification of HER - 2/neu and topoisomerase Ilalpha in primary and metastatic breast cancer. Cancer Res 2001; 61 (14):5345 - 8.
  • 8Lohrisch C, Piccart M. HER2/neu as a predictive factor in breast cancer. Clin Breast Cancer 2001; 2(2): 129 - 35.
  • 9Garkavtsev I, Kazatov A , Gudkov K, et al .Suppression of the nobel growth inhibor P33ING1ptomotes neoplastic transformation [J].Nat Gent , 1996,14:415-420.
  • 10丁厚中,杨海人,李海,蔡晓凤,李良波,李才华,吴晓阳,杨栋,冷新,倪灿荣,朱明华.P33^(ING1)在胃癌组织中的表达及其意义[J].第二军医大学学报,2001,22(1):57-60. 被引量:6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部